Imagine a world without cancer.
When doctors told Stefanie Joho that they had no options left, her sister scoured the internet to find "something" that could offer hope. She found… Read More »Stefanie Joho describes how she participated in a landmark clinical trial of immunotherapy
Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30… Read More »Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics
Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for… Read More »Lung cancer immunotherapy options expand
On a weekend before a business trip, Ken Brothers noticed some blood in his urine. He wondered if it was related his recent loss of… Read More »The State of the Bladder Cancer Battle
“There are an increasing collection of tests that sample other aspects of prostate cancer in urine, blood or tissue, including acquired gene defects in the… Read More »Is there any test for prostate cancer that doesn’t depend on a blood test for PSA?
No matter how you respond to your diagnosis, it’s not unusual for cancer patients to feel the impact of spiritual pain and distress, says Rhonda… Read More »What are the signs of spiritual distress for cancer patients?
“The best approach is to have a significant conversation with your physician about the risks and benefits of screening. It's shared decision making,” says William… Read More »How can I figure out if prostate cancer screening will help me personally?
“Don’t be shy. It is not a sign of weakness to want a person of faith by your side at a time like this,” says… Read More »What can a cancer chaplain do for me as a cancer patient?
At the annual Research Matters conference yesterday, top scientists from the Johns Hopkins Kimmel Cancer Center and University of Maryland Greenebaum Cancer Center discussed research using… Read More »Top Maryland scientists discuss research on tracking and treating cancer
Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins… Read More »What you need to know about prostate cancer screening guidelines